Form 4: Bicycle Therapeutics COO Sells Shares

Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics PLC, reported transactions involving the sale of ordinary shares.

Summary

• Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics PLC, reported the sale of 1,038 ordinary shares on April 2, 2026, at a weighted average price of $4.91.
• Further transactions on April 6, 2026, involved the sale of 37 ordinary shares at a weighted average price of $5.05 and 333 ordinary shares at a weighted average price of $5.04.
• The sale of 1,038 shares was to cover statutory tax withholding obligations related to the vesting of RSUs, as mandated by the award agreement.
• The sale of 333 shares was executed under a Rule 10b5-1 trading plan adopted on March 27, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the reported share sales by the COO are explained by standard tax withholding requirements and a pre-arranged trading plan, which are common and not indicative of negative insider sentiment.

Negatives

• Sale of company shares by a key executive, which could be perceived negatively by the market.
• The total number of shares sold across the reported transactions is 1,408.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, such as this one from Bicycle Therapeutics PLC, are standard disclosures for insider transactions. While sales by executives can sometimes raise concerns, the explanations provided (tax withholding and a pre-established 10b5-1 plan) suggest these are routine events rather than indicators of negative sentiment about the company's prospects.

Stakeholder Impact

• Shareholders may observe the sale of shares by a key executive, but the provided explanations for tax withholding and a 10b5-1 plan suggest these are not driven by negative company outlook.
• Employees may note the standard practice of RSU vesting and associated tax obligations for executives.

Key Dates

Keywords

Bicycle Therapeutics, BCYC, Form 4, Insider Trading, Share Sale, COO, RSU Vesting, Tax Withholding, 10b5-1 Plan